News for Protalix BioTherapeutics, Inc. (PLX.TA)

PR NewswireCARMIEL, Israel, March 24, 2025 CARMIEL, Israel, March 24, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharma

The global financial markets are experiencing heightened volatility, influenced by a confluence of economic and geopolitical factors.

Revenue from Selling Goods: $53 million for the year ended December 31, 2024, an increase of 31% from $40.4 million in 2023.Revenue from License and R&D Servic

Protalix BioTherapeutics, Inc. (NYSE:PLX) Q4 2024 Earnings Conference Call March 17, 2025 8:30 AM ETCompany ParticipantsMike Moyer - Investor Relations,...

PR NewswireCARMIEL, Israel, March 17, 2025 Company to host conference call and webcast today at 8:30 a.m. EDTCARMIEL, Israel, March 17, 2025 /PRNewswire/ -

PR NewswireCARMIEL, Israel, March 10, 2025 Company to host conference call and webcast at 8:30 a.m. EDTCARMIEL, Israel, March 10, 2025 /PRNewswire/ -- Prot

PR NewswireCARMIEL, Israel, Dec. 23, 2024 CARMIEL, Israel, Dec. 23, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE-American: PLX), a biopharmace

PR NewswirePARMA, Italy and CARMIEL Israel, Dec. 9, 2024 Application to label a less frequent dosing regimen at a dose of 2 mg/kg body weight administered

Operator: Good morning, ladies and gentlemen, and welcome to the Protalix BioTherapeutics Third Quarter 2024 Financial and Business Results Conference Call.

Protalix BioTherapeutics, Inc. (NYSE:PLX) Q3 2024 Results Earnings Conference Call November 14, 2024 8:30 AM ETCompany ParticipantsMike Moyer - Investor...

Protalix BioTherapeutics to Present at the  Life Sciences Investor Forum September  19, 2024

The Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com...

Protalix BioTherapeutics clears debt, secures operational runway

We recently published a list of 10 Best Rated Penny Stocks To Buy According to Analysts. In this article, we are going to take a look at where Protalix BioTherapeutics, Inc.

These stocks are making interesting moves on high volume. Active Stocks Moving Up Today QuickLogic Corporation (QUIK) < (QUIK) is currently trading at $6....

Revenue from Selling Goods: $13.3 million, a decrease of $1.8 million or 12% compared to $15.1 million in Q2 2023.Revenue from License and R&D Services: $0.2 m

Maryland-based biotechnology business Novavax, Inc. (NVAX) is up over 108% in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

/PRNewswire / Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of...

The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.00 A.M. ET)..